This opportunity is no longer accepting applications.
grant RFA-DA-25-022
Advancing Technologies to Improve Delivery of Pharmacological, Gene Editing, and other Cargoes for HIV and SUD Mechanistic or Therapeutic Research (R01 Clinical Trial Optional)
This grant supports the development of new technologies to enhance the delivery of drugs, gene editing, or other treatments for HIV and substance use disorders (SUD), as well as for related research purposes.
The purpose of this funding opportunity is to develop technologies to improve the delivery of pharmacological, gene editing, or other cargoes for HIV and SUD or mechanistic or therapeutic research
Funding Source
Agency: National Institutes of Health
Sub-agency: National Institute on Drug Abuse
Program: SBIR
Dates
Opportunity Released: November 1, 2023
Open for Submission: November 1, 2023
Submission Deadline: November 15, 2024
Application Window Closes: November 15, 2024
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers